An experimental drug from Eli Lilly has shown significant weight loss in clinical trials, with some reports indicating it reached levels comparable to surgery. The drug, known as retatrutide, reportedly helped patients lose around 28% of their body weight. The trials' results have been described as powerful and dramatic, although there are also indications of increased side effects.